Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Janknegt

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Pharmacy World & Science : PWS|June 1, 1997
The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerationsR Janknegt
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1996
Liposomal formulations of cytotoxic drugsR Janknegt
Pharmacy World & Science : PWS|August 20, 1993
Aminoglycoside monitoring in the once- or twice-daily era. The Dutch situation consideredR Janknegt
Pharmaceutisch Weekblad. Scientific Edition|February 21, 1986
Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacyR Janknegt
Pharmacoeconomics|November 10, 2001
Using health outcomes data to inform decision-making: formulary committee perspectiveR Janknegt
Pharmaceutisch Weekblad. Scientific Edition|August 21, 1992
Future directions in antimicrobial chemotherapyR Janknegt
Pharmacoeconomics|June 7, 1994
Fluoroquinolones: use of clinical data to aid formulary choice by the system of objective judgement analysis (SOJA) methodR Janknegt
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
CAPD peritonitis and fluoroquinolones: a reviewR Janknegt
The Journal of Antimicrobial Chemotherapy|November 1, 1990
Drug interactions with quinolonesR Janknegt
Pharmaceutisch Weekblad. Scientific Edition|August 23, 1991
Teicoplanin in perspective. A critical comparison with vancomycinR Janknegt
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Pharmacy World & Science : PWS|June 1, 1997
The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerationsR Janknegt
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1996
Liposomal formulations of cytotoxic drugsR Janknegt
Pharmacy World & Science : PWS|August 20, 1993
Aminoglycoside monitoring in the once- or twice-daily era. The Dutch situation consideredR Janknegt
Pharmaceutisch Weekblad. Scientific Edition|February 21, 1986
Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacyR Janknegt
Pharmacoeconomics|November 10, 2001
Using health outcomes data to inform decision-making: formulary committee perspectiveR Janknegt
Pharmaceutisch Weekblad. Scientific Edition|August 21, 1992
Future directions in antimicrobial chemotherapyR Janknegt
Pharmacoeconomics|June 7, 1994
Fluoroquinolones: use of clinical data to aid formulary choice by the system of objective judgement analysis (SOJA) methodR Janknegt
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
CAPD peritonitis and fluoroquinolones: a reviewR Janknegt
The Journal of Antimicrobial Chemotherapy|November 1, 1990
Drug interactions with quinolonesR Janknegt
Pharmaceutisch Weekblad. Scientific Edition|August 23, 1991
Teicoplanin in perspective. A critical comparison with vancomycinR Janknegt
Pageof 7